371 related articles for article (PubMed ID: 16732997)
1. Epstein-Barr virus and Hodgkin's lymphoma.
Andersson J
Herpes; 2006 May; 13(1):12-6. PubMed ID: 16732997
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-associated Hodgkin's lymphoma.
Gandhi MK; Tellam JT; Khanna R
Br J Haematol; 2004 May; 125(3):267-81. PubMed ID: 15086409
[TBL] [Abstract][Full Text] [Related]
3. [Hodgkin's disease and Epstein-Barr virus].
Depil S; Moralès O; Auriault C
Ann Biol Clin (Paris); 2004; 62(6):639-48. PubMed ID: 15563422
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin's disease patients: implications for a T-cell-based therapy.
Chapman AL; Rickinson AB; Thomas WA; Jarrett RF; Crocker J; Lee SP
Cancer Res; 2001 Aug; 61(16):6219-26. PubMed ID: 11507075
[TBL] [Abstract][Full Text] [Related]
5. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.
Demachi-Okamura A; Ito Y; Akatsuka Y; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
Eur J Immunol; 2006 Mar; 36(3):593-602. PubMed ID: 16479544
[TBL] [Abstract][Full Text] [Related]
7. Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin's lymphoma.
Claviez A; Tiemann M; Lüders H; Krams M; Parwaresch R; Schellong G; Dörffel W
J Clin Oncol; 2005 Jun; 23(18):4048-56. PubMed ID: 15961758
[TBL] [Abstract][Full Text] [Related]
8. Adoptive immunotherapy with allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes for recurrent, EBV-positive Hodgkin disease.
Lucas KG; Salzman D; Garcia A; Sun Q
Cancer; 2004 May; 100(9):1892-901. PubMed ID: 15112270
[TBL] [Abstract][Full Text] [Related]
9. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
[TBL] [Abstract][Full Text] [Related]
10. The relationships between Epstein-Barr virus latent membrane protein 1 and regulatory T cells in Hodgkin's lymphoma.
Marshall NA; Culligan DJ; Tighe J; Johnston PW; Barker RN; Vickers MA
Exp Hematol; 2007 Apr; 35(4):596-604. PubMed ID: 17379070
[TBL] [Abstract][Full Text] [Related]
11. Establishment of cytotoxic T lymphocytes specific for autologous Epstein-Barr virus in HIV-infected patients: the feasibility study of EBV-specific immunotherapy for patients with EBV-associated lymphoma.
Hansasuta P; Incomserb P; Buranapraditkun S; Bhattarakosol P
J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S146-51. PubMed ID: 16083179
[TBL] [Abstract][Full Text] [Related]
12. Hodgkin's lymphoma in Indian children: prevalence and significance of Epstein-Barr virus detection in Hodgkin's and Reed-Sternberg cells.
Dinand V; Dawar R; Arya LS; Unni R; Mohanty B; Singh R
Eur J Cancer; 2007 Jan; 43(1):161-8. PubMed ID: 17113770
[TBL] [Abstract][Full Text] [Related]
13. The effect of Epstein-Barr virus status on clinical outcome in Hodgkin's lymphoma.
Kwon JM; Park YH; Kang JH; Kim K; Ko YH; Ryoo BY; Lee SS; Lee SI; Koo HH; Kim WS
Ann Hematol; 2006 Jul; 85(7):463-8. PubMed ID: 16534596
[TBL] [Abstract][Full Text] [Related]
14. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr Virus and HLA-DPB1-*0301 in young adult Hodgkin's disease: evidence for inherited susceptibility to Epstein-Barr Virus in cases that are EBV(+ve).
Alexander FE; Jarrett RF; Cartwright RA; Armstrong AA; Gokhale DA; Kane E; Gray D; Lawrence DJ; Taylor GM
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):705-9. PubMed ID: 11401923
[TBL] [Abstract][Full Text] [Related]
16. Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases.
Cohen JI
Semin Hematol; 2003 Apr; 40(2):116-23. PubMed ID: 12704588
[TBL] [Abstract][Full Text] [Related]
17. [EBV-positive Hodgkin's lymphoma in children under 10 years].
Macák J; Plank L; Habanec B; Fabián P; Curík R; Nieslanik J; Bobot L; Vácha P; Utíkal Z; Dvorácková J
Vnitr Lek; 2000 Jul; 46(7):387-90. PubMed ID: 15635798
[TBL] [Abstract][Full Text] [Related]
18. Detection of Epstein-Barr virus in Hodgkin's lymphoma (patients in the Czech Republic).
Macák J; Habanec B; Fabián P
Neoplasma; 2000; 47(3):156-61. PubMed ID: 11043838
[TBL] [Abstract][Full Text] [Related]
19. Regulatory T cells and EBV associated malignancies.
Li J; Qian CN; Zeng YX
Int Immunopharmacol; 2009 May; 9(5):590-2. PubMed ID: 19539572
[TBL] [Abstract][Full Text] [Related]
20. Hodgkin's disease and peripheral T-cell lymphoma: composite lymphoma with evidence of Epstein-Barr virus infection.
Niedobitek G; Baumann I; Brabletz T; Lisner R; Winkelmann C; Helm G; Kirchner T
J Pathol; 2000 Aug; 191(4):394-9. PubMed ID: 10918214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
